Axa Non Currrent Assets Other from 2010 to 2024
| EQH Stock | USD 45.34 0.85 1.84% |
Non Currrent Assets Other | First Reported 2016-12-31 | Previous Quarter 209.4 B | Current Value -74.5 B | Quarterly Volatility 55.2 B |
Check Axa Equitable financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axa Equitable's main balance sheet or income statement drivers, such as Depreciation And Amortization of 545.7 M, Interest Expense of 174.7 M or Selling General Administrative of 2.4 B, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.022 or PTB Ratio of 4.62. Axa financial statements analysis is a perfect complement when working with Axa Equitable Valuation or Volatility modules.
Axa | Non Currrent Assets Other |
Latest Axa Equitable's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Axa Equitable Holdings over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Axa Equitable's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axa Equitable's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Axa Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | (22,051,946,667) | |
| Coefficient Of Variation | (479.52) | |
| Mean Deviation | 70,882,218,667 | |
| Median | (56,412,000,000) | |
| Standard Deviation | 105,743,037,299 | |
| Sample Variance | 11181589937.2T | |
| Range | 332.9B | |
| R-Value | 0.57 | |
| Mean Square Error | 8167780655.7T | |
| R-Squared | 0.32 | |
| Significance | 0.03 | |
| Slope | 13,411,230,714 | |
| Total Sum of Squares | 156542259120.6T |
Axa Non Currrent Assets Other History
About Axa Equitable Financial Statements
Investors use fundamental indicators, such as Axa Equitable's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Axa Equitable's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 227.7 B | 239 B |
Currently Active Assets on Macroaxis
When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:Check out the analysis of Axa Equitable Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Dividend Share 0.92 | Earnings Share 2.53 | Revenue Per Share 34.451 | Quarterly Revenue Growth 0.477 |
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.